Two FDA Press Releases out from $RGBP this week! Regen BioPharma Responds to FDA Comments on Its Application for Orphan Drug Designation on its Aplastic Anemia Therapy https://finance.yahoo.com/news/regen-biopharma-responds-fda-comments-120000009.html Regen BioPharma Receives Positive Data From Pre-clinical Studies of Its Small Molecule NR2F6 Modulators https://finance.yahoo.com/news/regen-biopharma-inc-receives-positive-121400084.html